null

Biotinylated Anti-VEGFA (Bevacizumab biosimiar) mAb (HDBS0269)

SKU:
HDBS0269
Antibody Type:
Biotinylated Biosimilar
Modifications:
Biotinylated
Applications:
IHC
SPR
FC
ELISA
Drug Development
Pharmacokinetics
Disease Area:
Angiogenesis
Disease Area:
Cancer
Disease Area:
Ocular Disorders
Size:
100 μg
Target:
VEGFA
Isotype:
IgG1
Host Species:
Humanized
Reactivity:
Human
€429

Description

system_update_altDatasheetsystem_update_altMSDS
Product Name:Biotinylated Anti-VEGFA (Bevacizumab biosimiar) mAb
SKU:HDBS0269
Size:100 μg
Target:VEGFA
Common Name:MVCD1,VEGF,VPF
Isotype:IgG1
Host Species:Humanized
Reactivity:Human
Synonyms:rhuMAb-VEGF
Applications:ELISA
Recommended Dilutions:ELISA 1:5000-10000
Conjugate:Biotinylated

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Uniprot:P15692
Formulation & Reconstitution:Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Usage:Research use only
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Related Products